Clinical trial
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
NCT06051942 is registered in ClinicalTrials.gov with PROCEPT BioRobotics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
- Lead sponsor
- PROCEPT BioRobotics
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 22, 2022
- Completion date
- March 31, 2027
- Enrollment
- 125 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostatic hyperplasia, localized prostate cancer